Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...
Posts from this topic will be added to your daily email digest and your homepage feed. If you want to tweak what’s on your feed, you can make a post and ask. If you want to tweak what’s on your feed, ...
Recursion Pharmaceuticals (RXRX) Falls More Steeply Than Broader Market: What Investors Need to Know
Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $3.85, moving -3.27% from the previous trading session. The stock's performance was behind the S&P 500's daily loss of 0.33%. On ...
The EU is threatening to take action against the social media company. It could be the start of a global reckoning. Katie is a UK-based news reporter and features writer. Officially, she is CNET's ...
The co-founders of startup Ricursive Intelligence seemed destined to be co-founders. Anna Goldie, CEO, and Azalia Mirhoseini, CTO, are so well-known in the AI community that they were among those AI ...
Use one of the services below to sign in to PBS: You've just tried to add this video to My List. But first, we need you to sign in to PBS using one of the services below. You've just tried to add this ...
Eric has been writing about tech for 30+ years. He manages PCMag’s Readers’ Choice program and leads a variety of special editorial projects.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results